B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With RituximabB 세포 번호는 리툭시맙으로 치료받은 환자의 SARS-CoV-2 백신 접종 시 체액 및 세포 반응을 예측합니다Article Published on 2022-06-012022-09-12 Journal: Arthritis & rheumatology (Hoboken, N.J.) [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] activated anti-SARS-CoV-2 Antibody Response antigen-specific B cell Autoimmune B cell Biomarker CD4 CD4 T cell CD4/CD8 CD8 T cell Cell cell differentiation cellular complex COVID-19 cytoplasmic Frequency function healthy control higher risk humoral humoral immune response IgG Inflammatory interferon-γ likelihood Lymphocytes Messenger RNA number outcome Patient patients peripheral circulation plasma receiving reduced required response rheumatic disease rheumatoid arthritis rituximab RTX SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine secretion Seroconversion T cell T cell subset Therapies therapy Vaccine Vaccines Vasculitis [DOI] 10.1002/art.42060 PMC 바로가기 [Article Type] Article
Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysisReview article Published on 2022-06-012022-10-05 Journal: Diabetes & metabolic syndrome [Category] 바이오마커, [키워드] Admission benefit BNT162b2 cardiovascular complications case sery Characteristics chest pain clinical outcomes conducted COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines develop disease dose ECG elevated female Fever Google help individual information LVEF male media median age median time Messenger RNA Meta-analysis Moderna Most patient mRNA mRNA vaccine mRNA-1273 myocarditis occurred participated Patient patients patients died Pfizer-BioNTech public health receiving recent reported symptom resolved Result Symptom systematic literature search systematic review troponin Vaccine vaccine dose Vaccines [DOI] 10.1016/j.dsx.2022.102513 [Article Type] Review article
Simultaneous Occurrence of Immune-Mediated Thrombocytopenia and Myocarditis After mRNA-1273 COVID-19 Vaccination: A Case ReportmRNA-1273 COVID-19 예방접종 후 면역매개성 혈소판감소증과 심근염의 동시 발생: 증례보고Case Reports Published on 2022-05-302022-09-11 Journal: Journal of Korean medical science [Category] 유전자 메커니즘, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration Admission assumed Blood blood test cardiac enzyme cardiac enzymes caused chest pain coronavirus COVID-19 discharged Dyspnea emergency department Endomyocardial biopsy expression Immunoglobulin incidence innate immune system Intravenous immunoglobulin marker mechanism Messenger RNA Mild Moderna mRNA mRNA vaccination mRNA-1273 mRNA-1273 vaccine myocarditis occur occurred Patient performed Platelet Platelet count problem report reported severe acute respiratory syndrome Coronavirus Simultaneous Spread sweating thrombocytopenia vaccination Vaccine [DOI] 10.3346/jkms.2022.37.e169 PMC 바로가기 [Article Type] Case Reports
A Case Report of Herpes Zoster Ophthalmicus and Meningitis After COVID-19 VaccinationCOVID-19 예방접종 후 대상포진 안과 및 수막염의 증례 보고Case Reports Published on 2022-05-232022-09-11 Journal: Journal of Korean medical science [Category] 대상포진, 두창, 수두, 치료기술, 치료제, 홍역, [키워드] acyclovir BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine cerebrospinal fluid Chain Reaction characterized Combination conjunctival conjunctival hyperemia Contact contact lens Corneal coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine diagnosed epithelial examination finding examination findings eye drops eyelid forehead growth factor haze headache Herpe herpes zoster Herpes Zoster Ophthalmicus hyperemia initiated intravenous keratitis left arm levofloxacin margin Meningitis Messenger RNA Mild mRNA Neurotrophic keratitis Neurotropic Keratitis. nose occur ofloxacin Patient polymerase chain polymerase chain reaction Reactivation receiving report scalp second dose skin rash slit-lamp therapeutic therapeutic contact lens treated ulcer upper eyelid vaccination Vaccine varicella Varicella zoster virus virus Zoster [DOI] 10.3346/jkms.2022.37.e165 PMC 바로가기 [Article Type] Case Reports
Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study예방 접종을 받은 암 환자의 SARS-CoV-2 돌발 감염 위험: 후향적 코호트 연구Article Published on 2022-05-212022-09-11 Journal: Journal of Hematology & Oncology [Category] COVID19(2023년), SARS, 변종, [키워드] Breakthrough infection cancer patient Cancer patients COVID curated database death rate death rates determine dose Effectiveness Efficacy General population Height hematologic Hematologic malignancy higher risk Hospitalization malignancies malignancy Messenger RNA mRNA mRNA vaccine Multiple myeloma Myeloma oncology outcome Patient patient data remained Research risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 infection severe SARS Therapies therapy university vaccination Vaccine variant [DOI] 10.1186/s13045-022-01290-8 PMC 바로가기 [Article Type] Article
Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review아데노바이러스 벡터화 및 mRNA COVID-19 백신을 사용한 이종 대 상동 프라임-부스트 일정의 면역원성 및 안전성: 체계적인 검토Review Published on 2022-05-132022-09-12 Journal: Infectious Diseases of Poverty [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Analysis Anti-spike BNT ChAdOx1 nCoV-19 comparable coronavirus disease COVID-19 COVID-19 vaccines database Evidence Heterologous heterologous prime-boost heterologous vaccination higher risk homologous Homologous vaccination immunogenicity Local local reaction Messenger RNA Meta-analysis mRNA mRNA-1273 neutralizing antibody Participants Protein reactogenicity risk Safety searched serum antibody spike-specific T cell supported systematic review systemic reaction T cell vaccination Vaccine Web of Science [DOI] 10.1186/s40249-022-00977-x PMC 바로가기 [Article Type] Review
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar카타르에서 SARS-CoV-2 오미크론 감염에 대한 mRNA 백신 부스터의 효과Article Published on 2022-05-122022-09-11 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 변종, 진단, 치료법, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 association B.1.1.529 B.1.617.2 BNT162b2 booster booster dose booster doses booster vaccination Cohort cohorts conducted coronavirus coronavirus disease Coronavirus disease 2019 cumulative cumulative incidence death dose Effect effective Effectiveness effort Follow-up Hospitalization incidence Infection less Messenger RNA Moderna mRNA mRNA-1273 mRNA-1273 vaccine of BNT162b2 omicron Pfizer-BioNTech protection regression models retrospective cohort study SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus symptomatic symptomatic infection symptomatic SARS-CoV-2 infection Vaccine variant variants with infection [DOI] 10.1056/NEJMoa2200797 PMC 바로가기 [Article Type] Article
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models자가 증폭 mRNA SARS-CoV-2 백신 후보는 전임상 모델에서 안전하고 강력한 보호 면역을 유도합니다Clinical Trial Published on 2022-05-042022-09-11 Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), MERS, SARS, 변종, 비임상, 임상, 진단, [키워드] (Alpha) (Beta Alpha animals Antigen B.1.1.7 B.1.351 B.1.617.2 Beta biodistribution breath CD4 CD8 T cell CD8 T cell responses characterized clinical evaluation Delta demonstrated disease dose-dependent manner Efficacy elicit elicited emergency response Evidence evidence of Frequency Germinal center hamsters humans immune responses immunization immunogenicity induce Lipid nanoparticle Lipid nanoparticles LNP lower airways Messenger RNA mice mRNA neutralized no evidence of Phase 1 Protective protective immune response protective immunity RATs reduced response RNA RNA vaccines robust Safe safety profile SAM SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 variants SARS-CoV-2 Wuhan strain self-amplifying mRNA Spike antigen spike-specific antibody response T cell the SARS-CoV-2 the vaccine Tolerance Toxicity upper and lower airways Vaccine vaccine candidate variants Viral Viral load Wuhan-Hu-1 [DOI] 10.1016/j.ymthe.2022.01.001 PMC 바로가기 [Article Type] Clinical Trial
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States중증 급성 호흡기 증후군 코로나바이러스 2 메신저 RNA 백신의 효과로 미국에서 코로나바이러스 질병 2019 입원 예방Multicenter Study Published on 2022-05-032022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults adults hospitalized Analysis black Case-control Control controls coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 Coverage COVID COVID-19 COVID-19 hospitalization effective Effectiveness evaluated highest Hispanic hospitalizations Hospitalized illness onset Immunocompromised Immunosuppressed Immunosuppression increased risk increases in Lineage median age messenger Messenger RNA Moderna mRNA mRNA vaccine mRNA vaccines multicenter outcomes Participants Patient Pfizer-BioNTech Prevent Preventing receipt respiratory RNA SARS-CoV-2 SARS-CoV-2 lineage SARS-CoV-2 vaccination severe acute respiratory syndrome Coronavirus severe coronavirus disease tested the United State The United States United States vaccination Vaccine vaccine dose vaccine effectiveness Vaccines variant virus with COVID-19 [DOI] 10.1093/cid/ciab687 PMC 바로가기 [Article Type] Multicenter Study
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 VaccineBNT162b2 mRNA COVID-19 백신 2~3회 투여 후 SARS-CoV-2 변이체에 대한 중화 항체 반응 평가Article Published on 2022-05-022022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] 95% CI Against age all age group all age groups assessment BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine booster booster vaccination cohort study conducted COVID-19 D614G variant delta variant dose group Immunity increase in induce Japanese Kobe lowest median age men Messenger RNA mRNA much higher Neutralizing antibodies neutralizing antibody Older age omicron Omicron variant other variant other variants outcome pandemic participant Participants physician Positive test positive test result recipient recipients response SARS-CoV-2 SARS-CoV-2 pandemic test results tested the SARS-CoV-2 the vaccine titer titers university vaccination Vaccine variant variants [DOI] 10.1001/jamanetworkopen.2022.10780 PMC 바로가기 [Article Type] Article